Core Viewpoint - The 2025 High-Performance New Energy Materials Industry Conference will focus on new materials, new dynamics, and new ecosystems in the energy sector, highlighting the importance of innovation and collaboration in the industry [1]. Group 1: Conference Overview - The conference is organized by Gaogong Lithium Battery, Gaogong Energy Storage, and Gaogong Industry Research Institute (GGII) [1]. - The event will take place from July 8 to July 9, 2025, in Chengdu, Sichuan, at the Yang'an New City Conference Center [1]. Group 2: Key Sessions and Topics - The opening ceremony will feature speeches from industry leaders, including Zhang Xiaofei, Chairman of Gaogong Lithium Battery, and representatives from local government and key companies [2][3]. - Key topics include the transformation of battery materials under diverse demands, industrial applications of composite materials, and the future opportunities in solid-state battery technology [3][4]. Group 3: Specialized Sessions - Specialized sessions will cover new material applications, innovations in solid-state battery materials, and the development of battery recycling technologies [4][5]. - Discussions will focus on the challenges and opportunities in the commercialization of new materials, including the need for cost reduction and supply chain security [4][5].

Group 1: Copper Industry - In May, domestic air conditioner sales increased by 2.3%, while production decreased by 1.8%. The copper industry is facing supply disruptions, with both domestic production and imports of scrap copper declining in May. Demand for air conditioning is weaker than expected, leading to potential risks in copper demand. Short-term copper prices are expected to remain volatile, with a gradual increase anticipated following domestic stimulus policies and potential interest rate cuts in the US [4]. Group 2: Oil and Gas Industry - The ongoing military conflict between Israel and Iran continues to dominate the crude oil market. On June 22, the US bombed Iranian nuclear facilities, marking its formal involvement in the Israel-Iran conflict. Despite geopolitical uncertainties, the medium to long-term supply-demand dynamics for crude oil remain favorable, with a continued positive outlook for major oil companies and related services [5]. Group 3: Agriculture and Animal Husbandry - The "618" shopping festival results indicate a significant growth in the pet economy, with over 400 pet brands reporting sales increases of over 100% year-on-year. The number of pet transaction users grew by 32%, and new pet owners increased by 39% [6]. Group 4: Coal Industry - The coal market is experiencing a supply contraction and a rebound in demand, suggesting that coal prices may have reached a temporary bottom. Port coal prices are stable, and there has been an increase in iron and steel production. Coal inventories at Qinhuangdao Port have decreased and are now lower than the same period last year [8]. Group 5: Renewable Energy and Environmental Protection - The wind power sector is advised to focus on wind turbine manufacturers, as second-quarter performance may be under pressure. The solid-state battery sector is seeing increased capital expenditure due to advancements in production lines and policy support. The photovoltaic sector is expected to benefit from upcoming supply and demand policies, with a focus on integrated companies with lower production costs [9]. Group 6: Retail Industry - The recent promotional period concluded with stable results, as e-commerce platforms reported a cumulative sales figure of 855.6 billion yuan, reflecting a 15.2% year-on-year increase. Instant retail sales reached 29.6 billion yuan, up 18.7% year-on-year. This year, platforms are focusing more on ecosystem building and consumer experience, with instant retail gaining traction [10]. Group 7: Pharmaceutical Industry - The review process for innovative drugs is accelerating, with the National Medical Products Administration seeking opinions on optimizing clinical trial approvals. This is expected to enhance the value of quality pipelines and improve market sentiment towards the innovative drug sector. Long-term, the policy aims to support the transition of Chinese innovative drugs from a combination of imitation and innovation to global original research [11].